1.
Marijuana school opens in Michigan
Monday, November 30
|
|
|
| SANGAMO BIOSCIENCES Add to My Watchlist | (NSDQ: SGMO) |
| Sangamo | 5.41 | +0.14 (+2.66%) | 255,138 |
| Profile for SGMO |
|
SANGAMO BIOSCIENCES 501 Canal Boulevard Suite A100 Richmond, CA 94804 http://www.sangamo.com |
|
|
Sangamo BioSciences is engaged in the research, development, and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes. Co. has a proprietary technology platform that is based on the engineering of a naturally occurring class of proteins referred to as zinc finger DNA-binding proteins (ZFPs). Also, ZFPs may be engineered to create zinc finger nucleases, or ZFNs , which can be used to cut genomic DNA at a pre-selected sequence location, enabling ZFN-mediated disruption of genes that are responsible for disease pathology, correction of genes that contain disease-causing mutations, or the targeted addition of a selected DNA sequence. |
|
| Headquarters for SGMO |
| Key Facts |
|
|
|
||
| Mr. Edward O. Lanphier II | Chief Executive Officer; President | |
| Mr. H. Ward Wolff | Chief Financial Officer; Executive Vice President | |
| Mr. David G. Ichikawa | Senior Vice President | |
| Dr. Philip D. Gregory D.Phil. | Vice President | |
| Mr. Gregory S. Zante | Vice President | |
| Dr. Dale G. Ando M.D. | Vice President; Chief Medical Officer | |
E-mail Article to a Friend
Most Popular
Stories
Photos
Videos
People
Monday, November 30
Monday, November 30
Monday, November 30
